Apr 28, 2019 - Galapagos NV (NASDAQ:GLPG) Q1 2019 Results Earnings Conference Call April 26, 2019 08:00 AM ET Company Participants Elizabeth Goodwin - VP of IR & Corporate Communications Onno van de Stolpe - Chi
Apr 26, 2019 - GLPG earnings call for the period ending March 31, 2019.
Apr 08, 2019 - Gilead (GILD) submits sNDA to the FDA for label expansion of Descovy as PrEP to reduce the risk of sexually acquired HIV-1 infection.
Apr 01, 2019 - Shares of Gilead Sciences and Teva Pharmaceutical Industries are bargains right now.
Mar 29, 2019 - Gilead (GILD) and partner Galapagos announce positive results from late-stage studies on investigational drug, filgotinib for the treatment of RA.
Feb 22, 2019 - Galapagos NV (NASDAQ:GLPG) Q4 2018 Earnings Conference Call February 22, 2019 08:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - Chief Executive Officer Bart
Dec 27, 2018 - AMAG's (AMAG) share improve 9.7% year to date courtesy of label expansion efforts as well as acquisitions and deals.
Nov 28, 2018 - Galapagos' (GLPG) GLPG1972/S201086 gets Fast Track designation by the FDA for the treatment of osteoarthritis.
Nov 19, 2018 - CHMP gives positive opinion to Vertex's (VRTX) label expansion of Orkambi.
Nov 12, 2018 - Bayer (BAYRY) is scheduled to report third-quarter earnings on Nov 13. Acquisition of Mosanto is expected to boost sales of Crop Science segment significantly.